← Leaderboards
Anthony F Suffredini
Clinical Center
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Center
Same institution · by research overlap
Others in their field
Top investigators on “Endotoxins”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Thomas William Geisbert · Boston University Medical Campus$36,787,680
- David B Peden · University Of North Carolina Chapel Hill$19,740,458
- Frederica P Perera · Columbia University Health Sciences$12,164,412
- Craig J McClain · University Of Louisville$11,315,007
- Edward A Fisher · Mount Sinai School Of Medicine Of Nyu$10,220,342
Research focus
EndotoxinsHuman SubjectGene ExpressionBacterial DiseaseClinical ResearchInflammationMicroarray TechnologyCytokineImmunogeneticsNitric OxideImmunoregulationVascular EndotheliumChemical Structure FunctionBlood ToxicologyRecombinant ProteinsImmunomodulatorsRespiratory Disorder ChemotherapyHuman Therapy EvaluationDiagnostic Respiratory LavageInhalation Drug AdministrationDisease /Disorder ModelAlveolar MacrophagesFlow CytometryLung Lavage
Grant awards (10)
Gene Expression And Protein Profiles In Humans Challenge$0
Z01 · FY2002 · CL
Inflammatory Effects Of High Mobility Group Protein 1$0
Z01 · FY2002 · CL
Effects Of Inhaled Nitric Oxide On Pulmonary Inflammator$0
Z01 · FY2002 · CL
Inflammatory Effects of High Mobility Group Protein 1$0
Z01 · FY2001 · CL
Gene Expression In Humans Challenged With Endotoxin$0
Z01 · FY2001 · CL
Inhaled Nitric Oxide On Pulmonary Inflammatory Responses$0
Z01 · FY2001 · CL
GENE EXPRESSION IN HUMANS CHALLENGED WITH ENDOTOXIN$0
Z01 · FY2000 · CL
Effects of Inhaled Nitric Oxide on Pulmonary Inflammatory Responses$0
Z01 · FY2000 · CL
GENE EXPRESSION IN HUMANS CHALLENGED WITH ENDOTOXIN$0
Z01 · FY2000 · CL
Effects of L-Arginine on Endotoxin-mediated Inflammatory Responses$0
Z01 · FY2000 · CL